SLNO Fails To Whet Investors' Appetite, OPNT And EBS Slump On Court Ruling, ENOB On Track

Today's Daily Dose brings you news about disappointing results from Soleno's Prader-Willi syndrome trial; the Court ruling in a patent infringement lawsuit filed by Opiant/Emergent against Teva; encouraging additional data from Sarepata's limb-girdle muscular dystrophy Type 2E trial; and Enochian's path forward for ENOB-HV-01, a potential cure for HIV.

from RTT - Biotech https://ift.tt/30mJkcT
via IFTTT